Furthermore, knockdown of NCAPD3 greatly inhibited the migratory and invasive capacity of NSCLC cells, which is consistent with the finding that lower NCAPD3 expression is correlated to a reduced risk of lymph node metastasis and a higher overall survival rate. This evidence concerns the gene NCAPD3 and non-small cell lung carcinoma.